Copyright (c) 2016 AJC
This work is licensed under a Creative Commons Attribution 4.0 International License.
Statistical Design Based on 90 % Confidence Intervals Analysis of Bioequivalence Studies of Sustained Release Capsules of Metoprolol Tartrate on Healthy Human Volunteers
Asian Journal of Chemistry,
Vol. 28 No. 10 (2016): Vol 28 Issue 10
Abstract
The bioequivalence study of formulations of sustained release coated granules equivalent to100 mg metoprolol tartrate (TEST-C1) with the reference formulation (Metolar XR 100SR) tablets of Cipla Ltd. was done. The study was typical two-period, randomized, two-way complete crossover design in 6 healthy, male human volunteers. There was 2 dosing sessions with a washout period of 7 days between the two sessions. Drug plasma samples were collected over a 24 h period after administration. Subsequently, plasma concentrations of drug were analyzed by using HPLC/UV. Pharmacokinetic parameters were determined by using non-compartmental analysis. The results showed that 90 % confidence intervals of the peak concentration (Cmax) and the area under the concentration-time curve (AUC) of reference and test were within the range 80-125 %. Consequently the bioequivalence of these two preparations can be concluded.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
- S. Siddique, A. Bose and J. Khanam, Drug Dev. Ind. Pharm., 37, 1016 (2011).
- A.M. Kaushal and S. Garg, Am. J. Drug Deliv., 1, 103 (2003).
- Y.S. Krishnaiah, R.S. Karthikeyan and V. Satyanarayana, Int. J. Pharm., 241, 353 (2002).
- S.M. Al-Saidan, Y.S. Krishnaiah, V. Satyanarayana, P. Bhaskar and R.S. Karthikeyan, Eur. J. Pharm. Biopharm., 58, 697 (2004).
- H. Ravishankar, P. Patil, A. Samel, H.U. Petereit, R. Lizio and J. Iyer-Chavan, J. Control. Rel., 111, 65 (2006).
- A. Ghosh, U.K. Bhaumik, A. Bose, U. Mandal, V. Gowda, B. Chatterjee, U.S. Chakrabarty and T.K. Pal, Biol. Pharm. Bull., 31, 1946 (2008).
- K.V. Gowda, D.S. Rajan, U. Mandal, W.D. Sam Solomon, P.S. Selvan, A. Bose, A.K. Sarkar, T.K. Chattaraj and T.K. Pal, Asian J. Chem., 19, 1293 (2007).
- WMA Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects. Tokyo WMAGa (2004).
- I.C.M.R. Guidelines, Ethical Guidelines For Biomedical Research on Human Participants, Indian Council of Medical Research, New Delhi, pp. 1-111 (2006).
- FDA, Guidance for Industry: Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research: Rockville, pp. 1-22 (2001).
- Committee for Proprietary Medicinal Products (CPMP), Note for Guidance: Investigation of Bioavailability and Bioequivalence, London: Working Party on the Efficacy of the Medicinal Products (1991).
- R.L. Nation and L.N. Sansom, Pharmacol. Ther., 62, 41 (1994).
- M. Gibaldi, Pharmacokinetic Variability-Drug Interactions, In: Biopharmaceutics and Clinical Pharmcokinetics, Lea and Febiger, Philadelphia, edn 4, p. 316 (1991).
- M. Aqil, A. Ali, A. Ahad, Y. Sultana, A. Najmi and N. Saha, Acta Chromatogr., 19, 130 (2007).
- A.K. Sarkar, D. Ghosh, A. Das, P.S. Selvan, K.V. Gowda, U. Mandal, A. Bose, S. Agarwal, U. Bhaumik and T.K. Pal, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 873, 77 (2008).
- J. Luch and K. Florey, Metoprolol Tartrate: Analytical Profiles of Drug Substances, Academic Press, New York, pp. 325-356 (1983).
- K.V. Gowda, D.S. Rajan, U. Mandal, P.S. Selvan, W.D. Sam Solomon, A. Bose, A.K. Sarkar, T.K. Pal and T.K. Chattaraj, Drug Dev. Ind. Pharm., 32, 1219 (2006).
- U. Mondal, M. Ganesan, T.K. Pal, M. Jayakumar, T.K. Chattaraj, K. Roy and S.N. Banerjee, J. Indian Med. Assoc., 102, 26 (2004).
- B. Sadaba, M.A. Campanero, M.J. Munoz-Juarez, I. Gil-Aldea, E. Garcia-Quetglas, A. Esteras and J.R. Azanza, Eur. J. Clin. Pharmacol., 62, 849 (2006).
- W.A. Ritschel, Handbook of Basic Pharmacokinetics, Drug Intelligence, Hamilton, edn. 4, p. 588 (1992).
References
S. Siddique, A. Bose and J. Khanam, Drug Dev. Ind. Pharm., 37, 1016 (2011).
A.M. Kaushal and S. Garg, Am. J. Drug Deliv., 1, 103 (2003).
Y.S. Krishnaiah, R.S. Karthikeyan and V. Satyanarayana, Int. J. Pharm., 241, 353 (2002).
S.M. Al-Saidan, Y.S. Krishnaiah, V. Satyanarayana, P. Bhaskar and R.S. Karthikeyan, Eur. J. Pharm. Biopharm., 58, 697 (2004).
H. Ravishankar, P. Patil, A. Samel, H.U. Petereit, R. Lizio and J. Iyer-Chavan, J. Control. Rel., 111, 65 (2006).
A. Ghosh, U.K. Bhaumik, A. Bose, U. Mandal, V. Gowda, B. Chatterjee, U.S. Chakrabarty and T.K. Pal, Biol. Pharm. Bull., 31, 1946 (2008).
K.V. Gowda, D.S. Rajan, U. Mandal, W.D. Sam Solomon, P.S. Selvan, A. Bose, A.K. Sarkar, T.K. Chattaraj and T.K. Pal, Asian J. Chem., 19, 1293 (2007).
WMA Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects. Tokyo WMAGa (2004).
I.C.M.R. Guidelines, Ethical Guidelines For Biomedical Research on Human Participants, Indian Council of Medical Research, New Delhi, pp. 1-111 (2006).
FDA, Guidance for Industry: Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research: Rockville, pp. 1-22 (2001).
Committee for Proprietary Medicinal Products (CPMP), Note for Guidance: Investigation of Bioavailability and Bioequivalence, London: Working Party on the Efficacy of the Medicinal Products (1991).
R.L. Nation and L.N. Sansom, Pharmacol. Ther., 62, 41 (1994).
M. Gibaldi, Pharmacokinetic Variability-Drug Interactions, In: Biopharmaceutics and Clinical Pharmcokinetics, Lea and Febiger, Philadelphia, edn 4, p. 316 (1991).
M. Aqil, A. Ali, A. Ahad, Y. Sultana, A. Najmi and N. Saha, Acta Chromatogr., 19, 130 (2007).
A.K. Sarkar, D. Ghosh, A. Das, P.S. Selvan, K.V. Gowda, U. Mandal, A. Bose, S. Agarwal, U. Bhaumik and T.K. Pal, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 873, 77 (2008).
J. Luch and K. Florey, Metoprolol Tartrate: Analytical Profiles of Drug Substances, Academic Press, New York, pp. 325-356 (1983).
K.V. Gowda, D.S. Rajan, U. Mandal, P.S. Selvan, W.D. Sam Solomon, A. Bose, A.K. Sarkar, T.K. Pal and T.K. Chattaraj, Drug Dev. Ind. Pharm., 32, 1219 (2006).
U. Mondal, M. Ganesan, T.K. Pal, M. Jayakumar, T.K. Chattaraj, K. Roy and S.N. Banerjee, J. Indian Med. Assoc., 102, 26 (2004).
B. Sadaba, M.A. Campanero, M.J. Munoz-Juarez, I. Gil-Aldea, E. Garcia-Quetglas, A. Esteras and J.R. Azanza, Eur. J. Clin. Pharmacol., 62, 849 (2006).
W.A. Ritschel, Handbook of Basic Pharmacokinetics, Drug Intelligence, Hamilton, edn. 4, p. 588 (1992).